EYPT logo

EyePoint Pharmaceuticals (EYPT) Return On Assets

Annual ROA

-26.44%
+19.65%+42.63%

December 31, 2023

Summary

Performance

1-Year Change

+42.63%

3-Year Change

+52.04%

5-Year Change

+55.7%

15-Year Change

+64.03%

EYPT ROA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

60.87%
EYPT annual return on assets is higher than 60.87% of companies in Healthcare sector

High & Low

All-time High

23.06%
EYPT annual return on assets is currently -214.66% below its historical high of 23.06%

3-Year Low

-46.09%

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
EYPT previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 7, 2025
EYPT next annual earnings announcement is scheduled for Mar 7, 2025

OtherEYPTprofitabilitymetrics:

Annual Revenue

$46.02 M
EYPT annual revenue is $46.02 million

Annual Net Income

-$70.80 M
EYPT annual net profit is -$70.80 million

Annual EPS

-$1.82
EYPT annual earnings per share is -$1.82

Annual ROE

-39.04%
EYPT annual return on equity is -39.04%

Quarterly ROA

-35.24%
-2.95%-9.14%

September 30, 2024

Summary

Performance

3-Month Change

-9.14%

1-Year Change

+37.28%

3-Year Change

+21.27%

5-Year Change

+21.27%

EYPT Quarterly ROA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

49.47%
EYPT quarterly return on assets is higher than 49.47% of companies in Healthcare sector

High & Low

All-time High

40.07%
EYPT quarterly return on assets is currently -187.95% below its historical high of 40.07%

3-Year Low

-56.19%

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
EYPT previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 7, 2025
EYPT next earnings announcement is scheduled for Mar 7, 2025

OtherEYPTprofitabilitymetrics:

Quarterly Revenue

$10.52 M
EYPT quarterly revenue is $10.52 million

Quarterly Net Income

-$29.36 M
EYPT quarterly net profit is -$29.36 million

Quarterly EPS

-$0.54
EYPT quarterly earnings per share is -$0.54

Quarterly ROE

-50.67%
EYPT quarterly return on equity is -50.67%

ROA Formula

ROA =  Net Income
Total Assets ✕ 100%

Annual ROA

-26.44%
EYPT annual return on assets is -26.44%

Annual Net Income

-$70.80 M
EYPT annual net profit is -$70.80 million

Annual Total Assets

$355.18 M
EYPT annual total assets is $355.18 million

EYPT ROA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+42.6%+37.3%
3 y3 years+52.0%+21.3%
5 y5 years+55.7%+21.3%

EYPT ROA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+42.6%-9.4%+37.3%
5 y5-yearat high+64.8%-9.4%+48.6%
alltimeall time-214.7%+77.5%-187.9%+79.1%

EyePoint Pharmaceuticals ROA History

DateAnnualQuarterly
Sep 2024
-
-35.24%(+9.1%)
Jun 2024
-
-32.29%(-3.9%)
Mar 2024
-
-33.59%(-2.7%)
Dec 2023
-26.44%(-42.6%)
-34.51%(-38.6%)
Sep 2023
-
-56.19%(+2.3%)
Jun 2023
-
-54.93%(+10.8%)
Mar 2023
-
-49.56%(+10.7%)
Dec 2022
-46.09%(+40.1%)
-44.76%(+29.3%)
Sep 2022
-
-34.61%(-1.5%)
Jun 2022
-
-35.15%(+9.2%)
Mar 2022
-
-32.20%(-1.9%)
Dec 2021
-32.90%(-40.3%)
-32.84%(-15.3%)
Sep 2021
-
-38.75%(+12.6%)
Jun 2021
-
-34.40%(-21.8%)
Mar 2021
-
-44.01%(-24.1%)
Dec 2020
-55.13%(-26.6%)
-57.98%(+8.9%)
Sep 2020
-
-53.24%(-19.7%)
Jun 2020
-
-66.33%(+6.0%)
Mar 2020
-
-62.55%(-8.8%)
Dec 2019
-75.15%(+25.9%)
-68.58%(-28.8%)
Sep 2019
-
-96.31%(-24.8%)
Jun 2019
-
-128.03%(-16.2%)
Mar 2019
-
-152.85%(-9.3%)
Dec 2018
-59.69%(-49.3%)
-
Sep 2018
-
-168.58%(+6.5%)
Jun 2018
-117.70%(+60.1%)
-158.22%(+44.9%)
Mar 2018
-
-109.16%(-20.9%)
Dec 2017
-
-137.93%(+50.1%)
Sep 2017
-
-91.87%(+11.8%)
Jun 2017
-73.50%(+9.1%)
-82.17%(+13.9%)
Mar 2017
-
-72.16%(+5.5%)
Dec 2016
-
-68.38%(-17.1%)
Sep 2016
-
-82.48%(+16.0%)
Jun 2016
-67.35%(-392.1%)
-71.08%(+9.0%)
Mar 2016
-
-65.23%(+2.8%)
Dec 2015
-
-63.46%(+18.9%)
Sep 2015
-
-53.36%(-393.7%)
Jun 2015
23.06%(-133.6%)
18.17%(-18.7%)
Mar 2015
-
22.36%(-33.6%)
Dec 2014
-
33.69%(-15.9%)
Sep 2014
-
40.07%(-165.1%)
Jun 2014
-68.63%
-61.55%(-3.1%)
Mar 2014
-
-63.53%(-8.9%)
DateAnnualQuarterly
Dec 2013
-
-69.73%(+9.6%)
Sep 2013
-
-63.60%(+7.3%)
Jun 2013
-64.59%(-12.0%)
-59.29%(+24.1%)
Mar 2013
-
-47.76%(+6.6%)
Dec 2012
-
-44.82%(-51.6%)
Sep 2012
-
-92.54%(+18.2%)
Jun 2012
-73.36%(+283.1%)
-78.28%(+27.5%)
Mar 2012
-
-61.40%(+9.6%)
Dec 2011
-
-56.03%(+214.1%)
Sep 2011
-
-17.84%(-7.9%)
Jun 2011
-19.15%(-187.6%)
-19.38%(-270.0%)
Mar 2011
-
11.40%(-8.5%)
Dec 2010
-
12.46%(-37.6%)
Sep 2010
-
19.98%(-19.1%)
Jun 2010
21.85%(-503.9%)
24.70%(-273.6%)
Mar 2010
-
-14.23%(+83.9%)
Dec 2009
-
-7.74%(-17.1%)
Sep 2009
-
-9.34%(+60.5%)
Jun 2009
-5.41%(-94.3%)
-5.82%(-94.8%)
Mar 2009
-
-111.33%(+15.6%)
Dec 2008
-
-96.28%(+13.2%)
Sep 2008
-
-85.08%(+12.0%)
Jun 2008
-95.61%(+27.9%)
-75.95%(+229.1%)
Mar 2008
-
-23.08%(-14.8%)
Dec 2007
-
-27.10%(-14.8%)
Sep 2007
-
-31.80%(-926.0%)
Jun 2007
-74.76%(+337.2%)
3.85%(-63.1%)
Mar 2007
-
10.43%(-17.8%)
Dec 2006
-
12.69%(+0.2%)
Sep 2006
-
12.66%(-203.3%)
Jun 2006
-17.10%(-34.4%)
-12.25%(-60.4%)
Mar 2006
-
-30.95%(+14.8%)
Dec 2005
-
-26.97%(+18.1%)
Sep 2005
-
-22.83%(+26.3%)
Jun 2005
-26.08%(+67.5%)
-18.07%(-42.7%)
Mar 2005
-
-31.55%(+32.0%)
Dec 2004
-
-23.91%(+48.2%)
Sep 2004
-
-16.13%(+83.1%)
Jun 2004
-15.57%(-59.6%)
-8.81%(-83.8%)
Mar 2004
-
-54.47%(+12.2%)
Dec 2003
-
-48.56%(+15.0%)
Sep 2003
-
-42.23%(+14.0%)
Jun 2003
-38.54%(+318.5%)
-37.03%
Jun 2001
-9.21%
-

FAQ

  • What is EyePoint Pharmaceuticals annual return on assets?
  • What is the all time high annual ROA for EyePoint Pharmaceuticals?
  • What is EyePoint Pharmaceuticals annual ROA year-on-year change?
  • What is EyePoint Pharmaceuticals quarterly return on assets?
  • What is the all time high quarterly ROA for EyePoint Pharmaceuticals?
  • What is EyePoint Pharmaceuticals quarterly ROA year-on-year change?

What is EyePoint Pharmaceuticals annual return on assets?

The current annual ROA of EYPT is -26.44%

What is the all time high annual ROA for EyePoint Pharmaceuticals?

EyePoint Pharmaceuticals all-time high annual return on assets is 23.06%

What is EyePoint Pharmaceuticals annual ROA year-on-year change?

Over the past year, EYPT annual return on assets has changed by +19.65% (+42.63%)

What is EyePoint Pharmaceuticals quarterly return on assets?

The current quarterly ROA of EYPT is -35.24%

What is the all time high quarterly ROA for EyePoint Pharmaceuticals?

EyePoint Pharmaceuticals all-time high quarterly return on assets is 40.07%

What is EyePoint Pharmaceuticals quarterly ROA year-on-year change?

Over the past year, EYPT quarterly return on assets has changed by +20.95% (+37.28%)